ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.458,47
1,24%
S&P 500
5.759,73
0,25%
Dow Jones
42.532,33
0,85%
Euro vs US Dollar
1,11816
0,05%
Bitcoin
66.287,49
1,69%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Taysha Gene Therapies Inc (TSHA)

  7. Taysha Gene Therapies Inc (TSHA) News

TSHA

Taysha Gene Therapies (TSHA)

Taysha Gene Therapies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TSHA
DatumZeitQuelleÜberschriftSymbolFirma
26/09/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome CongressNASDAQ:TSHATaysha Gene Therapies Inc
06/09/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
12/08/202414h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSHATaysha Gene Therapies Inc
12/08/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
12/08/202414h01GlobeNewswire Inc.Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
05/08/202414h00GlobeNewswire Inc.Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12NASDAQ:TSHATaysha Gene Therapies Inc
02/08/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
05/07/202423h51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
05/07/202423h50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
05/07/202423h49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
05/07/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
26/06/202415h14GlobeNewswire Inc.Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TSHATaysha Gene Therapies Inc
26/06/202400h34GlobeNewswire Inc.Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TSHATaysha Gene Therapies Inc
18/06/202413h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
18/06/202413h30GlobeNewswire Inc.Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
07/06/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
31/05/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
30/05/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
14/05/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
14/05/202422h12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSHATaysha Gene Therapies Inc
14/05/202422h01GlobeNewswire Inc.Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
07/05/202422h05GlobeNewswire Inc.Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14NASDAQ:TSHATaysha Gene Therapies Inc
03/05/202422h05GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
02/05/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
05/04/202414h00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
20/03/202418h30AllPennyStocks.comAnother Biotech Steals The Show Following Major Clinical Data ReleaseNASDAQ:TSHATaysha Gene Therapies Inc
19/03/202421h01GlobeNewswire Inc.Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:TSHATaysha Gene Therapies Inc
19/03/202412h27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:TSHATaysha Gene Therapies Inc
14/03/202421h26GlobeNewswire Inc.Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19NASDAQ:TSHATaysha Gene Therapies Inc
01/03/202423h08GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:TSHA

Kürzlich von Ihnen besucht

COIN
ETHUSD
Ethereum
AMEX
SPY
SPDR S&P 500
FX
EURJPY
Euro vs Yen
AMEX
XLV
Health Care Select Sector
FX
EURGBP
Euro vs Sterling
NYSE
JPM
JP Morgan Chase
USOTC
DTEGY
Deutsche Telekom (QX)
TG
MBG
MercedesBenz
COIN
AVAXUSD
Avalanche
NASDAQ
AMZN
Amazon.com
CCOM
SILVER
SILVER
FX
EURUSD
Euro vs US Dollar
NASDAQ
MSFT
Microsoft
TG
NOV
Novo Nordisk
COIN
SOLUSD
Solana
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten